To investigate the impact of ECM on GBM tumor cells, IHC of patient TMAs was used to analyze expression of laminin, vitronectin, and fibronectin in GBM and low-grade CNS tumors (Figure 1A). The gene discussed is LAMB2; the disease is glioblastoma.